Clinical Trials Logo

Filter by:
  • Suspended  
  • Page [1]
NCT ID: NCT01849640 Suspended - Clinical trials for Uncomplicated Plasmodium Falciparum Malaria

Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity

Start date: December 2012
Phase: N/A
Study type: Interventional

This is a two-arm, open label Treatment Study comparing the efficacy, safety, tolerability and pharmacokinetics of a three-day course of Dihydroartemisinin-Piperaquine (DP) with or without single-dose primaquine in patients with uncomplicated Plasmodium falciparum malaria. On the last day of DP therapy, volunteers will be randomized to receive either a single 45 mg dose of primaquine (PQ) or DP treatment only (no primaquine).